Zepbound, a popular weight loss drug, also seems to help people with obstructive sleep apnea, drugmaker Eli Lilly said ...

The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk’s ...

In two trials of people with sleep apnea, Zepbound reduced the number of times breathing slowed or stopped during sleep.

Zepbound, a drug that rivals Ozempic, may one day be a treatment for sleep apnea, according to results from a new study.

Zepbound, one of the wildly popular weight-loss drugs that millions of Americans now take, eased sleep apnea in obese adults ...

In a new study, people with obesity who received weight-loss drug Zepbound saw a greater average reduction in sleep apnea ...

Zepbound, by Eli Lilly, may improve sleep apnea symptoms in those with the condition. Sleep experts explain how the weight ...

The new class of weight-loss drugs isn't just for diabetes and weight loss. Eli Lilly results from a large-scale trial show ...

Eli Lilly said on Wednesday its weight-loss drug helped reduce episodes of irregular breathing associated with a common sleep ...

Preliminary clinical trial results showed the obesity drug tirzepatide was highly effective at treating obstructive sleep ...

Eli Lilly noted that tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults that have both obstructive ...

Zepbound, a popular weight loss drug, also seems to help people with obstructive sleep apnea, drugmaker Eli Lilly said ...